Mouse models of atherosclerosis in translational research

I Ilyas, PJ Little, Z Liu, Y Xu, D Kamato, BC Berk… - Trends in …, 2022 - cell.com
Atherosclerotic cardiovascular disease (CVD), the major cause of premature human
mortality, is a chronic and progressive metabolic and inflammatory disease in large-and …

Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology

W Liang, AL Menke, A Driessen, GH Koek… - PloS one, 2014 - journals.plos.org
Background and aims The recently developed histological scoring system for non-alcoholic
fatty liver disease (NAFLD) by the NASH Clinical Research Network (NASH-CRN) has been …

The emerging landscape of peptide-based inhibitors of PCSK9

BJ Tombling, Y Zhang, YH Huang, DJ Craik, CK Wang - Atherosclerosis, 2021 - Elsevier
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a clinically validated target for
treating cardiovascular disease (CVD) due to its involvement in cholesterol metabolism …

Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit

Z Li, CX Yi, S Katiraei, S Kooijman, E Zhou, CK Chung… - Gut, 2018 - gut.bmj.com
Objective Butyrate exerts metabolic benefits in mice and humans, the underlying
mechanisms being still unclear. We aimed to investigate the effect of butyrate on appetite …

VEGFB/VEGFR1-induced expansion of adipose vasculature counteracts obesity and related metabolic complications

MR Robciuc, R Kivelä, IM Williams, JF de Boer… - Cell metabolism, 2016 - cell.com
Impaired angiogenesis has been implicated in adipose tissue dysfunction and the
development of obesity and associated metabolic disorders. Here, we report the unexpected …

FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis

C Liu, M Schönke, B Spoorenberg, JM Lambooij… - Elife, 2023 - elifesciences.org
Analogues of the hepatokine fibroblast growth factor 21 (FGF21) are in clinical development
for type 2 diabetes and nonalcoholic steatohepatitis (NASH) treatment. Although their …

Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis

C Liu, M Schönke, E Zhou, Z Li… - Cardiovascular …, 2022 - academic.oup.com
Aims Fibroblast growth factor (FGF) 21, a key regulator of energy metabolism, is currently
evaluated in humans for treatment of type 2 diabetes and non-alcoholic steatohepatitis …

[HTML][HTML] Dietary butyrate ameliorates metabolic health associated with selective proliferation of gut Lachnospiraceae bacterium 28-4

Z Li, E Zhou, C Liu, H Wicks, S Yildiz, F Razack, Z Ying… - JCI insight, 2023 - ncbi.nlm.nih.gov
Short-chain fatty acids, including butyrate, have multiple metabolic benefits in individuals
who are lean but not in individuals with metabolic syndrome, with the underlying …

Akkermansia muciniphila Exerts Lipid‐Lowering and Immunomodulatory Effects without Affecting Neointima Formation in Hyperlipidemic APOE*3‐Leiden.CETP Mice

S Katiraei, MR de Vries, AH Costain… - Molecular nutrition & …, 2020 - Wiley Online Library
Scope Akkermansia muciniphila (A. muciniphila) is an intestinal commensal with anti‐
inflammatory properties both in the intestine and other organs. The aim is to investigate the …

In vivo magnetic resonance imaging‐based detection of heterogeneous endothelial response in thoracic and abdominal aorta to short‐term high‐fat diet ascribed to …

A Bar, A Kieronska‐Rudek, B Proniewski… - Journal of the …, 2020 - Am Heart Assoc
Background Long‐term feeding with a high‐fat diet (HFD) induces endothelial dysfunction in
mice, but early HFD‐induced effects on endothelium have not been well characterized …